Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Erythromycin-nonsusceptible Streptococcus pneumoniae in children, 1999-2001.

McEllistrem MC, Adams JM, Shutt K, Sanza LT, Facklam RR, Whitney CG, Jorgensen JH, Harrison LH.

Emerg Infect Dis. 2005 Jun;11(6):969-72.

2.

Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment.

Stephens DS, Zughaier SM, Whitney CG, Baughman WS, Barker L, Gay K, Jackson D, Orenstein WA, Arnold K, Schuchat A, Farley MM; Georgia Emerging Infections Program.

Lancet. 2005 Mar 5-11;365(9462):855-63.

PMID:
15752529
3.

Molecular characteristics of erythromycin-resistant Streptococcus pneumoniae from pediatric patients younger than five years in Beijing, 2010.

Zhou L, Ma X, Gao W, Yao KH, Shen AD, Yu SJ, Yang YH.

BMC Microbiol. 2012 Oct 9;12:228. doi: 10.1186/1471-2180-12-228.

4.
5.

Mechanisms of macrolide resistance among Streptococcus pneumoniae isolates from Russia.

Reinert RR, Filimonova OY, Al-Lahham A, Grudinina SA, Ilina EN, Weigel LM, Sidorenko SV.

Antimicrob Agents Chemother. 2008 Jun;52(6):2260-2. doi: 10.1128/AAC.01270-07. Epub 2008 Mar 31.

6.

Macrolide resistance determinants in erythromycin-resistant Streptococcus pneumoniae in Turkey.

Gulay Z, Ozbek OA, Bicmen M, Gur D.

Jpn J Infect Dis. 2008 Nov;61(6):490-3.

7.

Prevalence of mef and ermB genes in invasive pediatric erythromycin-resistant Streptococcus pneumoniae isolates from Argentina.

Corso A, Faccone D, Gagetti P, Pace J, Regueira M, Pace J; Argentinean Sireva Working Group.

Rev Argent Microbiol. 2009 Jan-Mar;41(1):29-33. Erratum in: Rev Argent Microbiol. 2009 Apr-Jun;41(2):119.

PMID:
19391523
8.

Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines.

Hampton LM, Farley MM, Schaffner W, Thomas A, Reingold A, Harrison LH, Lynfield R, Bennett NM, Petit S, Gershman K, Baumbach J, Beall B, Jorgensen J, Glennen A, Zell ER, Moore M.

J Infect Dis. 2012 Feb 1;205(3):401-11. doi: 10.1093/infdis/jir755. Epub 2011 Dec 7.

PMID:
22158567
9.

Clonal spread of mef-positive macrolide-resistant Streptococcus pneumoniae isolates causing invasive disease in adults in Germany.

van der Linden M, Al-Lahham A, Haupts S, Reinert RR.

Antimicrob Agents Chemother. 2007 May;51(5):1830-4. Epub 2007 Feb 26.

10.

Nasopharyngeal Streptococcus pneumoniae carriage in Japanese children attending day-care centers.

Hashida K, Shiomori T, Hohchi N, Ohkubo J, Ohbuchi T, Mori T, Suzuki H.

Int J Pediatr Otorhinolaryngol. 2011 May;75(5):664-9. doi: 10.1016/j.ijporl.2011.02.005. Epub 2011 Mar 2.

PMID:
21371759
11.

Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.

Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D, McCracken GH Jr.

Pediatr Infect Dis J. 2007 Jun;26(6):461-7.

PMID:
17529859
12.

Regional differences in the epidemiology of invasive pneumococcal disease in toddlers in Germany.

Siedler A, Reinert RR, Toschke M, Al-Lahham A, von Kries R; ESPED Clinic and Laboratory Study Group.

Pediatr Infect Dis J. 2005 Dec;24(12):1114-5.

PMID:
16371880
13.

Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?

Fenoll A, Aguilar L, Granizo JJ, Giménez MJ, Aragoneses-Fenoll L, Mendez C, Tarragó D.

J Antimicrob Chemother. 2008 Dec;62(6):1430-3. doi: 10.1093/jac/dkn413. Epub 2008 Sep 26.

PMID:
18819966
14.
15.

Erythromycin resistance among invasive pneumococci in Scotland, 1994-2003.

Clarke SC, Reid JA, Thom L, Diggle MA, McChlery S, Scott K, Edwards GF.

Br J Biomed Sci. 2005;62(1):28-30. No abstract available.

PMID:
15816209
16.

Serotypes and antimicrobial susceptibilities of 1033 pneumococci isolated from children in Greece during 2001-2004.

Paraskakis I, Kafetzis DA, Chrisakis A, Papavasilliou H, Kirikou H, Pangalis A, Tzouvelekis LS, Athanasiou T, Legakis NJ; National Surveillance Network for Pneumococcal Resistance.

Clin Microbiol Infect. 2006 May;12(5):490-3.

17.

Streptococcus pneumoniae serotype 19A in children, South Korea.

Choi EH, Kim SH, Eun BW, Kim SJ, Kim NH, Lee J, Lee HJ.

Emerg Infect Dis. 2008 Feb;14(2):275-81. doi: 10.3201/eid1402.070807.

18.

Erythromycin resistance caused by erm(A) subclass erm(TR) in a Danish invasive pneumococcal isolate: are erm(A) pneumococcal isolates overlooked?

Lambertsen L, Ekelund K, Hansen DS, Kaltoft M, Christensen JJ, Hammerum AM.

Scand J Infect Dis. 2008;40(6-7):584-7. doi: 10.1080/00365540701854717.

PMID:
18584554
19.

Prevalence and phenotypes of erythromycin-resistant Streptococcus pneumoniae in Shanghai, China.

Wang M, Zhang Y, Zhu D, Wang F.

Diagn Microbiol Infect Dis. 2001 Mar;39(3):187-9.

PMID:
11337187
20.

Antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Ireland.

Clarke P, Murchan S, Smyth EG, Humphreys H.

Clin Microbiol Infect. 2004 Jul;10(7):657-9.

Supplemental Content

Support Center